Vol. 11 • Na. 1 • March 2009

In this issue:

• Treatment of Opioid Dependence and ADHD/ADD with Opioid Maintenance and Central Stimulants
  Blix O., Dalteg A., Nilsson P.
• Dihydrocodeine for the Treatment of Alcohol Dependence
  Ulmer A., Müller M., Frietsch B.
• Use and Abuse of High-Dose Buprenorphine (HDB) Obtained Without a Prescription: a French Survey
  Courty P.
• A 10-Year Evaluation of Chronic Pain Patients Treated with Opioids
  Tennant F.
• Psychotherapeutic Experiences with Methadone Maintained Patients in the Framework of Multidisciplinary Clinical Institution
  Todorov O.
• Preferences for Buprenorphine/Naloxone (Suboxone®) and Buprenorphine (Subutex®) in Patients Receiving Buprenorphine Maintenance Therapy in France: A Prospective, Multicentre Study
  Daulouède J.-P., Caer Y., Galland P., Villeger P., Brunelle E., Bachellier J., Piquet J.-M., Harbonnier J., Leglise Y., Courty P.
• Coordinating Methadone Treatment Providers and Policymakers: Lessons Learned Over 30 Years
  Parrino M. W.
• En Route to 90% Retention. ‘Active Rehabilitation' in Central Norway
  Nordstrand B.

Vol. 11 • Na. 2 • June 2009

In this issue:

• Swedish Use and Misuse of the Dole & Nyswander Treatment
  Gunne L.
• Methadone-treated Patients After Switching to Buprenorphine in Residential Therapeutic Communities: An Addiction-specific Assessment of Quality of Life
  González-Saiz F., Gómez R. B., Bilbao Acedos I., Lozano Rojas O., Gutiérrez Ortega J.
• Clinical trial on the use of olanzapine in reducing the consumption of cocaine in Methadone Maintenance Programmes
  Vázquez M. L., Castillo I. I., Jiménez-Lerma J. M., Beldarrain J. A. H., Gutiérrez-Fraile M.
• Voices of Experience: Attitudes and Opinions of Recipients of Unsupervised Injectable Opiate Treatment in the Northwest of England
  Orgel M., Wilson A., Leavey R., Sell L., Zador D.
• Substitution Therapy. A New Problem of Biomedical Ethics and Medical Law
  Mendelevich V. D.
• New Approaches in the Treatment of Opioid Dependency During the Pregnancy
  Finnegan L., Winklbaur B., Fischer G., May O., Welle-Strand G.
• QTc Interval Screening. American Association for the Treatment of Opioid Dependance (AATOD) Policy and Guidance Statement
  Parrino M., Aatod Board of Directors

Vol. 11 • Na. 3 • September 2009

In this issue:

• Methadone Treatment in Italy in the Third Millennium: Continuing Fear of Treatment
  Maremmani I.
• Pharmacology and Neurochemistry of Methadone
  Vendramin A., Sciacchitano A. M.
• Cannabis and Premonitory Symptoms of Schizophrenia: What Is the Time Sequence?
  Vernex N., Dagher G., Touzeau D.
• Alcoholics With a History of Heroin Consumption: Clinical Features and Chronology of Substance Abuse
  Ceccanti M., Vitali M.
• Opioid Dependence and Quality of Life: Changes in the Heroin Epidemic
  Domingo-Salvany A.
• Predictors for Non-Relapsing in Methadone- and Buprenorphine-maintained Heroin Addicts: A Comparative Study
  Maremmani I., Pacini M., Lamanna F., Maremmani A. G. I., Pani P. P., Perugi G., Gerra G.
• Echoing the Patient's Lack of Insight: A Role We Must Avoid Playing
  Pacini M.

Vol. 11 • Na. 4 • December 2009

In this issue:

• QT Interval
  Caldarola P., Cuonzo M.
• Psychoactive Drugs and Prolongation of the QT Interval
  Deruvo G., Vendramin A., Di Sciascio G.
• Opioid Treatment and “Long-QT Syndrome (LQTS)”: a Critical Review of the Literature
  Pacini M., Maremmani A. G. I., Dell' Osso L., Maremmani I.
• Management of Cardiac Risk during Methadone Treatment: Focus on the QT Interval
  Pani P. P.
• Cardiovascular Complications of Cocaine Use
  Gambarana C.